FDA recall record

Tamarack ECLIPSE Kratom Premium Maeng Da, 40 count capsules and 2 oz recall — FDA F-0992-2018

Tamarack Inc. is recalling Eclipse Kratom-containing powder products because it may be contaminated with Salmonella.

Class Iclassification
F-0992-2018official record ID
Apr 11, 2018report date

Recall record at a glance

Official recordF-0992-2018
CategoryFood Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmTamarack, Inc.
Report dateApr 11, 2018
Recall initiation dateMar 19, 2018
Quantity120 units
LocationRoy, UT, United States

Official product description

ECLIPSE Kratom Premium Maeng Da, 40 count capsules and 2 oz bottles, Distributed by Tamarack Inc. Cheyenne, WY

Why the product was recalled

Tamarack Inc. is recalling Eclipse Kratom-containing powder products because it may be contaminated with Salmonella.

Distribution information

Distributed to retail stores in Utah. No foreign/VA/govt/military consignees.

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.